Preferences and Insights for Participation in a Rheumatoid Arthritis Clinical Prevention Trial: A Mixed‐Methods Study
Open Access
- 16 September 2022
- journal article
- research article
- Published by Wiley in ACR Open Rheumatology
- Vol. 4 (11) , 974-982
Abstract
Objective: In rheumatoid arthritis (RA), anti–citrullinated protein antibodies (ACPA) can be elevated prior to inflammatory arthritis (IA). The potential to intervene in people with ACPA positivity underpins the development of prevention trials in RA. The Research Participation Influences Study examined factors influencing the decisions of individuals who are ACPA(+) to participate in a prevention trial using qualitative and quantitative methods.Methods: Individuals with ACPA positivity without IA were provided information regarding their risk for future RA, were provided a description of a clinical prevention trial using hydroxychloroquine, and were asked if they would participate in the trial. After agreeing to or declining participation, they were surveyed on what influenced their decision using Likert scales and open‐response questions.Results: Thirty‐nine individuals who agreed to trial participation (enrollees) and 31 individuals who declined (nonenrollees) completed surveys. Enrollees expressed greater perceived risk for RA and greater perception of benefit to themselves or others than nonenrollees. Nonenrollees expressed greater concern about medication effects and less personal or family experience with RA than enrollees. There was a higher proportion of first‐degree relatives (FDRs) of people with RA in enrollees versus nonenrollees (54% vs. 23%, P = 0.01).Conclusion: Enrollees were more likely than nonenrollees to be FDRs, exhibit stronger concern for personal risk for RA, and have less concern about adverse effects. Further exploration is needed to determine why these differences were present, including exploration of symptoms and the role of family history. Understanding these issues will better inform researchers and individuals who are candidates for prevention.Keywords
Funding Information
- MSFHR (16813)
This publication has 20 references indexed in Scilit:
- Preventing rheumatoid arthritis: Preferences for and predicted uptake of preventive treatments among high risk individualsPLOS ONE, 2019
- I Would Never Take Preventive Medication! Perspectives and Information Needs of People Who Underwent Predictive Tests for Rheumatoid ArthritisArthritis Care & Research, 2019
- Effects of B-cell directed therapy on the preclinical stage of rheumatoid arthritis: the PRAIRI studyAnnals of the Rheumatic Diseases, 2019
- Study of Anti-Malarials in Incomplete Lupus Erythematosus (SMILE): study protocol for a randomized controlled trialTrials, 2018
- Perspectives of patients, first-degree relatives and rheumatologists on preventive treatments for rheumatoid arthritis: a qualitative analysisBMC Rheumatology, 2018
- Preventive Treatments for Rheumatoid Arthritis: Issues Regarding Patient PreferencesCurrent Rheumatology Reports, 2016
- Predicting the development of clinical arthritis in anti-CCP positive individuals with non-specific musculoskeletal symptoms: a prospective observational cohort studyAnnals of the Rheumatic Diseases, 2015
- A prediction rule for the development of arthritis in seropositive arthralgia patientsAnnals of the Rheumatic Diseases, 2013
- Effect of dexamethasone on autoantibody levels and arthritis development in patients with arthralgia: a randomised trialAnnals of the Rheumatic Diseases, 2010
- A Systematic Approach for Using Qualitative Methods in Primary Prevention ResearchMedical Anthropology Quarterly, 1990